Share Price and Basic Stock Data
Last Updated: January 2, 2026, 8:35 pm
| PEG Ratio | 19.07 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Symphony Ltd operates in the consumer electronics sector, primarily focusing on the air cooling segment. The company’s sales have shown a steady growth trajectory, rising from ₹1,039 Cr in FY 2022 to ₹1,188 Cr in FY 2023. However, the sales for FY 2024 are reported at ₹1,156 Cr, indicating a slight decline in revenue year-on-year. The most recent quarterly sales figures reflect this trend, with ₹275 Cr reported in September 2023 and a further dip to ₹247 Cr in December 2023. Despite this, the company has demonstrated resilience in its ability to generate sales, with a peak of ₹393 Cr in June 2024. This fluctuation in sales underscores the seasonal nature of the air cooling market, which is heavily influenced by climatic conditions. Symphony’s revenue from operations per share for FY 2025 stands at ₹229.53, showcasing its operational efficiency in generating income from its equity base.
Profitability and Efficiency Metrics
Symphony Ltd has maintained a commendable profitability profile, with a reported net profit of ₹130 Cr and a net profit margin of 13.48% for FY 2025. The operating profit margin (OPM) has shown variability, recorded at 15% for the current period, reflecting effective cost management despite fluctuations in sales. The company’s return on equity (ROE) stands at an impressive 32.4%, indicating effective utilization of shareholders’ funds. Furthermore, the return on capital employed (ROCE) is reported at 36.8%, which is notably high compared to industry norms, reflecting operational efficiency. The interest coverage ratio (ICR) is robust at 36.38x, showcasing Symphony’s ability to meet its interest obligations comfortably, with minimal debt reported at ₹5 Cr. This strong financial positioning allows Symphony to navigate market challenges effectively while capitalizing on growth opportunities.
Balance Sheet Strength and Financial Ratios
The balance sheet of Symphony Ltd indicates a strong financial position, with total assets standing at ₹1,322 Cr and a very low level of borrowings at ₹5 Cr. This translates to a total debt to equity ratio of 0.16, reflecting prudent financial management and minimal reliance on debt financing. Reserves have steadily increased to ₹769 Cr, which supports the company’s capacity for reinvestment and shareholder returns. The company’s book value per share, reported at ₹110.79, provides a solid base for its stock valuation, currently trading at a price-to-book value ratio of 10.11x. Other key financial ratios such as the current ratio at 1.24 and quick ratio at 0.71 suggest adequate liquidity to cover short-term obligations. This balance sheet strength positions Symphony favorably against competitors, enabling it to withstand economic fluctuations and invest in growth initiatives.
Shareholding Pattern and Investor Confidence
Symphony Ltd’s shareholding structure reveals a strong promoter backing, with promoters holding 73.42% of the total shares. This significant stake reflects confidence in the company’s long-term strategy and governance. Foreign institutional investors (FIIs) account for 5.98%, while domestic institutional investors (DIIs) hold 8.84%, indicating a balanced interest from institutional players. The public shareholding stands at 11.77%, with the total number of shareholders recorded at 136,778, suggesting a growing retail investor base. The stability in promoter shareholding over the past quarters, alongside gradual increases in FIIs, indicates a positive sentiment towards Symphony’s market positioning and growth potential. This confidence is critical as it underpins the stock’s valuation and can influence future capital raising efforts.
Outlook, Risks, and Final Insight
Looking ahead, Symphony Ltd faces both opportunities and challenges. The company’s strong market presence and innovative product offerings position it well for growth in the consumer electronics sector. However, risks such as fluctuating raw material costs and seasonality in demand could impact profitability and sales stability. Additionally, increasing competition from both domestic and international players may pressure market share and margins. The company’s ability to adapt to market trends and consumer preferences will be crucial. If Symphony leverages its strong balance sheet to invest in new technologies and expand its product range, it can enhance its competitive advantage. Conversely, failure to navigate these challenges could hinder growth prospects. Overall, Symphony’s solid fundamentals provide a strong foundation, but vigilance in market dynamics will be essential for sustained success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Misquita Engineering Ltd | 52.5 Cr. | 112 | 140/78.1 | 309 | 30.6 | 0.00 % | 1.86 % | 1.92 % | 10.0 |
| IKIO Lighting Ltd | 1,430 Cr. | 185 | 304/165 | 80.8 | 74.5 | 0.00 % | 8.22 % | 5.55 % | 10.0 |
| Epack Durable Ltd | 2,701 Cr. | 281 | 674/246 | 66.1 | 99.4 | 0.00 % | 9.70 % | 5.98 % | 10.0 |
| Elin Electronics Ltd | 826 Cr. | 167 | 234/108 | 21.6 | 112 | 0.00 % | 6.97 % | 4.38 % | 5.00 |
| CWD Ltd | 912 Cr. | 415 | 417/162 | 107 | 47.9 | 0.00 % | 9.51 % | 5.78 % | 10.0 |
| Industry Average | 15,622.56 Cr | 1,097.07 | 67.76 | 124.70 | 0.19% | 14.89% | 11.51% | 6.44 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 274 | 277 | 308 | 302 | 275 | 247 | 332 | 393 | 289 | 242 | 381 | 251 | 163 |
| Expenses | 237 | 233 | 285 | 276 | 234 | 203 | 275 | 306 | 212 | 213 | 282 | 225 | 139 |
| Operating Profit | 37 | 44 | 23 | 26 | 41 | 44 | 57 | 87 | 77 | 29 | 99 | 26 | 24 |
| OPM % | 14% | 16% | 7% | 9% | 15% | 18% | 17% | 22% | 27% | 12% | 26% | 10% | 15% |
| Other Income | 14 | 14 | 10 | 14 | 11 | 15 | 9 | 9 | 4 | -39 | 11 | 29 | 7 |
| Interest | 2 | 3 | 3 | 3 | 2 | 3 | 2 | 0 | 0 | 2 | 0 | 0 | 0 |
| Depreciation | 6 | 7 | 7 | 7 | 7 | 6 | 6 | 2 | 2 | 6 | 2 | 2 | 3 |
| Profit before tax | 43 | 48 | 23 | 30 | 43 | 50 | 58 | 94 | 79 | -18 | 108 | 53 | 28 |
| Tax % | 26% | 19% | 30% | 20% | 19% | 18% | 17% | 6% | 29% | -44% | 27% | 21% | 32% |
| Net Profit | 32 | 39 | 16 | 24 | 35 | 41 | 48 | 88 | 56 | -10 | 79 | 42 | 19 |
| EPS in Rs | 4.72 | 5.57 | 2.29 | 3.48 | 5.08 | 5.95 | 6.96 | 12.76 | 8.15 | -1.46 | 11.50 | 6.12 | 2.77 |
Last Updated: December 28, 2025, 11:04 pm
Below is a detailed analysis of the quarterly data for Symphony Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 163.00 Cr.. The value appears to be declining and may need further review. It has decreased from 251.00 Cr. (Jun 2025) to 163.00 Cr., marking a decrease of 88.00 Cr..
- For Expenses, as of Sep 2025, the value is 139.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 225.00 Cr. (Jun 2025) to 139.00 Cr., marking a decrease of 86.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26.00 Cr. (Jun 2025) to 24.00 Cr., marking a decrease of 2.00 Cr..
- For OPM %, as of Sep 2025, the value is 15.00%. The value appears strong and on an upward trend. It has increased from 10.00% (Jun 2025) to 15.00%, marking an increase of 5.00%.
- For Other Income, as of Sep 2025, the value is 7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 29.00 Cr. (Jun 2025) to 7.00 Cr., marking a decrease of 22.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Jun 2025) to 3.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Jun 2025) to 28.00 Cr., marking a decrease of 25.00 Cr..
- For Tax %, as of Sep 2025, the value is 32.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Jun 2025) to 32.00%, marking an increase of 11.00%.
- For Net Profit, as of Sep 2025, the value is 19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 42.00 Cr. (Jun 2025) to 19.00 Cr., marking a decrease of 23.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 2.77. The value appears to be declining and may need further review. It has decreased from 6.12 (Jun 2025) to 2.77, marking a decrease of 3.35.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:33 am
| Metric | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 487 | 525 | 446 | 764 | 798 | 844 | 1,103 | 900 | 1,039 | 1,188 | 1,156 | 1,576 | 1,037 |
| Expenses | 364 | 393 | 309 | 565 | 579 | 711 | 889 | 759 | 877 | 1,048 | 985 | 1,264 | 859 |
| Operating Profit | 123 | 132 | 136 | 199 | 220 | 133 | 213 | 140 | 162 | 140 | 171 | 312 | 178 |
| OPM % | 25% | 25% | 31% | 26% | 28% | 16% | 19% | 16% | 16% | 12% | 15% | 20% | 17% |
| Other Income | 16 | 34 | 33 | 43 | 54 | 15 | 51 | 24 | 40 | 50 | 48 | 1 | 8 |
| Interest | 0 | 1 | 0 | 1 | 2 | 8 | 13 | 12 | 10 | 12 | 12 | 11 | 2 |
| Depreciation | 4 | 4 | 4 | 7 | 7 | 10 | 21 | 21 | 24 | 26 | 26 | 22 | 13 |
| Profit before tax | 135 | 161 | 165 | 235 | 265 | 130 | 230 | 131 | 168 | 152 | 181 | 280 | 171 |
| Tax % | 22% | 28% | 28% | 29% | 27% | 30% | 21% | 18% | 28% | 24% | 18% | 24% | |
| Net Profit | 106 | 116 | 118 | 166 | 193 | 92 | 182 | 107 | 121 | 116 | 148 | 212 | 130 |
| EPS in Rs | 15.10 | 16.56 | 16.91 | 23.77 | 27.52 | 13.19 | 25.94 | 15.34 | 17.20 | 16.64 | 21.48 | 30.94 | 18.93 |
| Dividend Payout % | 43% | 42% | 74% | 19% | 16% | 34% | 89% | 33% | 52% | 30% | 61% | 42% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 40.68% | 16.27% | -52.33% | 97.83% | -41.21% | 13.08% | -4.13% | 27.59% | 43.24% |
| Change in YoY Net Profit Growth (%) | 0.00% | -24.41% | -68.60% | 150.16% | -139.03% | 54.29% | -17.22% | 31.72% | 15.66% |
Symphony Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 7% |
| 3 Years: | 15% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 6% |
| 3 Years: | 27% |
| TTM: | -3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 2% |
| 3 Years: | 1% |
| 1 Year: | -40% |
| Return on Equity | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 19% |
| 3 Years: | 21% |
| Last Year: | 32% |
Last Updated: September 5, 2025, 1:41 pm
Balance Sheet
Last Updated: December 4, 2025, 2:04 am
| Month | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 269 | 299 | 312 | 451 | 598 | 652 | 625 | 745 | 825 | 867 | 735 | 747 | 769 |
| Borrowings | 0 | 0 | 0 | 19 | 26 | 188 | 210 | 219 | 254 | 232 | 170 | 142 | 5 |
| Other Liabilities | 118 | 116 | 104 | 121 | 119 | 211 | 215 | 236 | 267 | 281 | 291 | 419 | 629 |
| Total Liabilities | 393 | 423 | 422 | 605 | 757 | 1,065 | 1,064 | 1,214 | 1,361 | 1,394 | 1,210 | 1,322 | 1,417 |
| Fixed Assets | 70 | 68 | 77 | 79 | 82 | 237 | 318 | 354 | 355 | 351 | 327 | 322 | 94 |
| CWIP | 8 | 0 | 3 | 0 | 0 | 6 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 199 | 242 | 162 | 292 | 422 | 458 | 412 | 484 | 500 | 527 | 373 | 440 | 565 |
| Other Assets | 117 | 112 | 180 | 234 | 252 | 363 | 332 | 375 | 506 | 516 | 510 | 560 | 758 |
| Total Assets | 393 | 423 | 422 | 605 | 757 | 1,065 | 1,064 | 1,214 | 1,361 | 1,394 | 1,210 | 1,322 | 1,417 |
Below is a detailed analysis of the balance sheet data for Symphony Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 14.00 Cr..
- For Reserves, as of Sep 2025, the value is 769.00 Cr.. The value appears strong and on an upward trend. It has increased from 747.00 Cr. (Mar 2025) to 769.00 Cr., marking an increase of 22.00 Cr..
- For Borrowings, as of Sep 2025, the value is 5.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 142.00 Cr. (Mar 2025) to 5.00 Cr., marking a decrease of 137.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 629.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 419.00 Cr. (Mar 2025) to 629.00 Cr., marking an increase of 210.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,417.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,322.00 Cr. (Mar 2025) to 1,417.00 Cr., marking an increase of 95.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 94.00 Cr.. The value appears to be declining and may need further review. It has decreased from 322.00 Cr. (Mar 2025) to 94.00 Cr., marking a decrease of 228.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 565.00 Cr.. The value appears strong and on an upward trend. It has increased from 440.00 Cr. (Mar 2025) to 565.00 Cr., marking an increase of 125.00 Cr..
- For Other Assets, as of Sep 2025, the value is 758.00 Cr.. The value appears strong and on an upward trend. It has increased from 560.00 Cr. (Mar 2025) to 758.00 Cr., marking an increase of 198.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,417.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,322.00 Cr. (Mar 2025) to 1,417.00 Cr., marking an increase of 95.00 Cr..
Notably, the Reserves (769.00 Cr.) exceed the Borrowings (5.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 123.00 | 132.00 | 136.00 | 180.00 | 194.00 | -55.00 | 3.00 | -79.00 | -92.00 | -92.00 | 1.00 | 170.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
No data available for the Financial Efficiency data table.
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Mid Cap Fund | 3,712,095 | 0.35 | 319.89 | N/A | N/A | N/A |
| HDFC Multi Cap Fund | 684,137 | 0.3 | 58.96 | 657,914 | 2025-12-15 04:53:37 | 3.99% |
| UTI Value Fund | 613,781 | 0.52 | 52.89 | 734,784 | 2025-12-08 01:30:12 | -16.47% |
| HDFC Retirement Savings Fund - Equity | 316,228 | 0.39 | 27.25 | N/A | N/A | N/A |
| Bandhan Flexi Cap Fund | 212,246 | 0.24 | 18.29 | N/A | N/A | N/A |
| HDFC Housing Opportunities Fund | 160,268 | 1.07 | 13.81 | N/A | N/A | N/A |
| HDFC Equity Savings Fund | 101,006 | 0.15 | 8.7 | N/A | N/A | N/A |
| Axis ESG Integration Strategy Fund | 83,001 | 0.58 | 7.15 | 83,302 | 2025-12-08 01:30:12 | -0.36% |
| UTI Conservative Hybrid Fund | 24,145 | 0.12 | 2.08 | 40,000 | 2025-12-08 00:03:04 | -39.64% |
| Quantum ESG Best In Class Strategy Fund | 11,035 | 0.92 | 0.95 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 30.89 | 21.43 | 16.64 | 17.20 | 15.35 |
| Diluted EPS (Rs.) | 30.89 | 21.43 | 16.64 | 17.20 | 15.35 |
| Cash EPS (Rs.) | 34.19 | 25.23 | 20.35 | 20.73 | 18.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 110.79 | 108.63 | 125.93 | 120.77 | 109.21 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 110.79 | 108.63 | 125.93 | 120.77 | 109.21 |
| Revenue From Operations / Share (Rs.) | 229.53 | 167.67 | 169.77 | 148.55 | 128.64 |
| PBDIT / Share (Rs.) | 52.10 | 31.86 | 26.96 | 28.68 | 24.36 |
| PBIT / Share (Rs.) | 48.86 | 28.11 | 23.18 | 25.22 | 21.30 |
| PBT / Share (Rs.) | 40.73 | 26.24 | 21.72 | 23.95 | 18.75 |
| Net Profit / Share (Rs.) | 30.95 | 21.48 | 16.57 | 17.28 | 15.35 |
| NP After MI And SOA / Share (Rs.) | 30.95 | 21.48 | 16.64 | 17.20 | 15.35 |
| PBDIT Margin (%) | 22.69 | 19.00 | 15.88 | 19.30 | 18.94 |
| PBIT Margin (%) | 21.28 | 16.76 | 13.65 | 16.98 | 16.55 |
| PBT Margin (%) | 17.74 | 15.65 | 12.79 | 16.12 | 14.57 |
| Net Profit Margin (%) | 13.48 | 12.81 | 9.75 | 11.63 | 11.93 |
| NP After MI And SOA Margin (%) | 13.48 | 12.81 | 9.80 | 11.57 | 11.92 |
| Return on Networth / Equity (%) | 27.94 | 19.77 | 13.21 | 14.33 | 14.13 |
| Return on Capital Employeed (%) | 42.45 | 23.24 | 16.15 | 17.57 | 15.75 |
| Return On Assets (%) | 15.92 | 12.16 | 8.29 | 8.80 | 8.80 |
| Long Term Debt / Equity (X) | 0.00 | 0.07 | 0.09 | 0.13 | 0.18 |
| Total Debt / Equity (X) | 0.16 | 0.19 | 0.22 | 0.26 | 0.24 |
| Asset Turnover Ratio (%) | 1.24 | 0.88 | 0.71 | 0.57 | 0.50 |
| Current Ratio (X) | 1.24 | 1.61 | 1.80 | 2.30 | 2.53 |
| Quick Ratio (X) | 0.71 | 1.01 | 1.18 | 1.82 | 2.10 |
| Inventory Turnover Ratio (X) | 6.12 | 0.56 | 0.00 | 0.00 | 0.04 |
| Dividend Payout Ratio (NP) (%) | 42.13 | 27.92 | 60.09 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 38.14 | 23.78 | 48.96 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 57.87 | 72.08 | 39.91 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 61.86 | 76.22 | 51.04 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 36.38 | 21.08 | 18.44 | 22.49 | 15.91 |
| Interest Coverage Ratio (Post Tax) (X) | 27.30 | 15.45 | 12.33 | 14.55 | 11.69 |
| Enterprise Value (Cr.) | 7775.84 | 5953.91 | 7242.13 | 7834.17 | 8991.19 |
| EV / Net Operating Revenue (X) | 4.93 | 5.15 | 6.10 | 7.54 | 9.99 |
| EV / EBITDA (X) | 21.74 | 27.11 | 38.40 | 39.05 | 52.76 |
| MarketCap / Net Operating Revenue (X) | 4.88 | 5.06 | 5.98 | 7.39 | 9.82 |
| Retention Ratios (%) | 57.86 | 72.07 | 39.90 | 0.00 | 0.00 |
| Price / BV (X) | 10.11 | 7.81 | 8.06 | 9.14 | 11.64 |
| Price / Net Operating Revenue (X) | 4.88 | 5.06 | 5.98 | 7.39 | 9.82 |
| EarningsYield | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Symphony Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 30.89. This value is within the healthy range. It has increased from 21.43 (Mar 24) to 30.89, marking an increase of 9.46.
- For Diluted EPS (Rs.), as of Mar 25, the value is 30.89. This value is within the healthy range. It has increased from 21.43 (Mar 24) to 30.89, marking an increase of 9.46.
- For Cash EPS (Rs.), as of Mar 25, the value is 34.19. This value is within the healthy range. It has increased from 25.23 (Mar 24) to 34.19, marking an increase of 8.96.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 110.79. It has increased from 108.63 (Mar 24) to 110.79, marking an increase of 2.16.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 110.79. It has increased from 108.63 (Mar 24) to 110.79, marking an increase of 2.16.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 229.53. It has increased from 167.67 (Mar 24) to 229.53, marking an increase of 61.86.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 52.10. This value is within the healthy range. It has increased from 31.86 (Mar 24) to 52.10, marking an increase of 20.24.
- For PBIT / Share (Rs.), as of Mar 25, the value is 48.86. This value is within the healthy range. It has increased from 28.11 (Mar 24) to 48.86, marking an increase of 20.75.
- For PBT / Share (Rs.), as of Mar 25, the value is 40.73. This value is within the healthy range. It has increased from 26.24 (Mar 24) to 40.73, marking an increase of 14.49.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 30.95. This value is within the healthy range. It has increased from 21.48 (Mar 24) to 30.95, marking an increase of 9.47.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 30.95. This value is within the healthy range. It has increased from 21.48 (Mar 24) to 30.95, marking an increase of 9.47.
- For PBDIT Margin (%), as of Mar 25, the value is 22.69. This value is within the healthy range. It has increased from 19.00 (Mar 24) to 22.69, marking an increase of 3.69.
- For PBIT Margin (%), as of Mar 25, the value is 21.28. This value exceeds the healthy maximum of 20. It has increased from 16.76 (Mar 24) to 21.28, marking an increase of 4.52.
- For PBT Margin (%), as of Mar 25, the value is 17.74. This value is within the healthy range. It has increased from 15.65 (Mar 24) to 17.74, marking an increase of 2.09.
- For Net Profit Margin (%), as of Mar 25, the value is 13.48. This value exceeds the healthy maximum of 10. It has increased from 12.81 (Mar 24) to 13.48, marking an increase of 0.67.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 13.48. This value is within the healthy range. It has increased from 12.81 (Mar 24) to 13.48, marking an increase of 0.67.
- For Return on Networth / Equity (%), as of Mar 25, the value is 27.94. This value is within the healthy range. It has increased from 19.77 (Mar 24) to 27.94, marking an increase of 8.17.
- For Return on Capital Employeed (%), as of Mar 25, the value is 42.45. This value is within the healthy range. It has increased from 23.24 (Mar 24) to 42.45, marking an increase of 19.21.
- For Return On Assets (%), as of Mar 25, the value is 15.92. This value is within the healthy range. It has increased from 12.16 (Mar 24) to 15.92, marking an increase of 3.76.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.07 (Mar 24) to 0.00, marking a decrease of 0.07.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.16. This value is within the healthy range. It has decreased from 0.19 (Mar 24) to 0.16, marking a decrease of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.24. It has increased from 0.88 (Mar 24) to 1.24, marking an increase of 0.36.
- For Current Ratio (X), as of Mar 25, the value is 1.24. This value is below the healthy minimum of 1.5. It has decreased from 1.61 (Mar 24) to 1.24, marking a decrease of 0.37.
- For Quick Ratio (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 1. It has decreased from 1.01 (Mar 24) to 0.71, marking a decrease of 0.30.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.12. This value is within the healthy range. It has increased from 0.56 (Mar 24) to 6.12, marking an increase of 5.56.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 42.13. This value is within the healthy range. It has increased from 27.92 (Mar 24) to 42.13, marking an increase of 14.21.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 38.14. This value is within the healthy range. It has increased from 23.78 (Mar 24) to 38.14, marking an increase of 14.36.
- For Earning Retention Ratio (%), as of Mar 25, the value is 57.87. This value is within the healthy range. It has decreased from 72.08 (Mar 24) to 57.87, marking a decrease of 14.21.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 61.86. This value is within the healthy range. It has decreased from 76.22 (Mar 24) to 61.86, marking a decrease of 14.36.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 36.38. This value is within the healthy range. It has increased from 21.08 (Mar 24) to 36.38, marking an increase of 15.30.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 27.30. This value is within the healthy range. It has increased from 15.45 (Mar 24) to 27.30, marking an increase of 11.85.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,775.84. It has increased from 5,953.91 (Mar 24) to 7,775.84, marking an increase of 1,821.93.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.93. This value exceeds the healthy maximum of 3. It has decreased from 5.15 (Mar 24) to 4.93, marking a decrease of 0.22.
- For EV / EBITDA (X), as of Mar 25, the value is 21.74. This value exceeds the healthy maximum of 15. It has decreased from 27.11 (Mar 24) to 21.74, marking a decrease of 5.37.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.88. This value exceeds the healthy maximum of 3. It has decreased from 5.06 (Mar 24) to 4.88, marking a decrease of 0.18.
- For Retention Ratios (%), as of Mar 25, the value is 57.86. This value is within the healthy range. It has decreased from 72.07 (Mar 24) to 57.86, marking a decrease of 14.21.
- For Price / BV (X), as of Mar 25, the value is 10.11. This value exceeds the healthy maximum of 3. It has increased from 7.81 (Mar 24) to 10.11, marking an increase of 2.30.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.88. This value exceeds the healthy maximum of 3. It has decreased from 5.06 (Mar 24) to 4.88, marking a decrease of 0.18.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Symphony Ltd:
- Net Profit Margin: 13.48%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 42.45% (Industry Average ROCE: 14.89%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 27.94% (Industry Average ROE: 11.51%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 27.3
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.71
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 36.9 (Industry average Stock P/E: 67.76)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.16
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 13.48%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Consumer Electronics | Symphony House, Third Floor, FP-12, Ahmedabad Gujarat 380059 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Achal Bakeri | Chairman & Managing Director |
| Mr. Nrupesh Shah | Managing Director - Corporate Affairs |
| Mr. Amit Kumar | Executive Director & Group CEO |
| Mr. Jonaki Bakeri | Non Executive Director |
| Mr. Naishadh Parikh | Independent Director |
| Mr. Ashish Deshpande | Independent Director |
| Mrs. Reena Bhagwati | Independent Director |
| Mr. Santosh Nema | Independent Director |
| Mr. Malavika Harita | Independent Director |
FAQ
What is the intrinsic value of Symphony Ltd?
Symphony Ltd's intrinsic value (as of 03 January 2026) is ₹1105.83 which is 20.72% higher the current market price of ₹916.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹6,316 Cr. market cap, FY2025-2026 high/low of ₹1,455/838, reserves of ₹769 Cr, and liabilities of ₹1,417 Cr.
What is the Market Cap of Symphony Ltd?
The Market Cap of Symphony Ltd is 6,316 Cr..
What is the current Stock Price of Symphony Ltd as on 03 January 2026?
The current stock price of Symphony Ltd as on 03 January 2026 is ₹916.
What is the High / Low of Symphony Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Symphony Ltd stocks is ₹1,455/838.
What is the Stock P/E of Symphony Ltd?
The Stock P/E of Symphony Ltd is 36.9.
What is the Book Value of Symphony Ltd?
The Book Value of Symphony Ltd is 114.
What is the Dividend Yield of Symphony Ltd?
The Dividend Yield of Symphony Ltd is 1.42 %.
What is the ROCE of Symphony Ltd?
The ROCE of Symphony Ltd is 36.8 %.
What is the ROE of Symphony Ltd?
The ROE of Symphony Ltd is 32.4 %.
What is the Face Value of Symphony Ltd?
The Face Value of Symphony Ltd is 2.00.